ATE433458T1 - Modulatoren von ship-1 - Google Patents

Modulatoren von ship-1

Info

Publication number
ATE433458T1
ATE433458T1 AT03714589T AT03714589T ATE433458T1 AT E433458 T1 ATE433458 T1 AT E433458T1 AT 03714589 T AT03714589 T AT 03714589T AT 03714589 T AT03714589 T AT 03714589T AT E433458 T1 ATE433458 T1 AT E433458T1
Authority
AT
Austria
Prior art keywords
ship
modulators
activity
pelorol
synthesis
Prior art date
Application number
AT03714589T
Other languages
English (en)
Inventor
Raymond Andersen
David Williams
Alice Mui
Christopher Ong
Gerald Krystal
Lu Yang
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2002/001550 external-priority patent/WO2003033517A1/en
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE433458T1 publication Critical patent/ATE433458T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Amplitude Modulation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03714589T 2002-10-17 2003-04-23 Modulatoren von ship-1 ATE433458T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CA2002/001550 WO2003033517A1 (en) 2001-10-17 2002-10-17 Ship 1 modulators
PCT/CA2003/000571 WO2004035601A1 (en) 2002-10-17 2003-04-23 Ship 1 modulators

Publications (1)

Publication Number Publication Date
ATE433458T1 true ATE433458T1 (de) 2009-06-15

Family

ID=32097361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03714589T ATE433458T1 (de) 2002-10-17 2003-04-23 Modulatoren von ship-1

Country Status (7)

Country Link
EP (1) EP1554304B1 (de)
JP (1) JP4753581B2 (de)
AT (1) ATE433458T1 (de)
CA (1) CA2502293C (de)
DE (1) DE60327936D1 (de)
ES (1) ES2327829T3 (de)
WO (1) WO2004035601A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2656339A1 (en) * 2006-06-21 2007-12-27 The University Of British Columbia Ship 1 modulator prodrugs
CA2781661A1 (en) 2009-12-04 2011-06-09 Aquinox Pharmaceuticals Inc. Ship1 modulators and methods related thereto
KR101978527B1 (ko) 2011-03-10 2019-09-03 엑스에리스 파머수티클스, 인크. 펩티드 약물의 비경구 주입을 위한 안정한 제형
US9125805B2 (en) * 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
KR20150106895A (ko) 2013-01-09 2015-09-22 에퀴녹스 파머수티칼스 (캐나다) 인코포레이티드 Ship1 조절제 및 그와 관련된 방법
HK1220173A1 (zh) 2013-03-14 2017-04-28 Aquinox Pharmaceuticals (Canada) Inc. Ship1调节剂和与其相关的方法
CA2902768A1 (en) 2013-03-14 2014-10-02 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators and methods related thereto
CN106573106B (zh) 2014-08-06 2021-06-22 Xeris药物公司 用于皮内和/或皮下注射糊剂的注射器、试剂盒和方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
JP2018518494A (ja) 2015-06-26 2018-07-12 アクイノックス ファーマシューティカルズ （カナダ） インコーポレイテッド （１Ｓ，３Ｓ，４Ｒ）−４−（（３ａＳ，４Ｒ，５Ｓ，７ａＳ）−４−（アミノメチル）−７ａ−メチル−１−メチレンオクタヒドロ−１Ｈ−インデン−５−イル）−３−（ヒドロキシメチル）−４−メチルシクロヘキサノールの酢酸塩の結晶固体形態
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
US10053415B2 (en) 2016-01-20 2018-08-21 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
WO2018126040A1 (en) 2016-12-28 2018-07-05 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3- (hydroxymethyl)-4-methylcyclohexanol
US11020403B2 (en) 2017-06-02 2021-06-01 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations
WO2021213393A1 (en) * 2020-04-20 2021-10-28 Zebrapeutics Inc. Method of treating ship1-mediated diseases using pelorol derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2463136A1 (en) * 2001-10-17 2003-04-24 Raymond Andersen Ship 1 modulators

Also Published As

Publication number Publication date
EP1554304A1 (de) 2005-07-20
EP1554304B1 (de) 2009-06-10
DE60327936D1 (de) 2009-07-23
CA2502293A1 (en) 2004-04-29
CA2502293C (en) 2011-09-06
JP2006506363A (ja) 2006-02-23
ES2327829T3 (es) 2009-11-04
JP4753581B2 (ja) 2011-08-24
WO2004035601A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
ATE533743T1 (de) Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1
SE0301653D0 (sv) Novel compounds
ATE433458T1 (de) Modulatoren von ship-1
ATE433447T1 (de) Pyrimiidinverbindungen
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
ATE369755T1 (de) Verwendung von diphenylmethan-derivaten als tyrosinase-inhibitoren
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
ES2173480T3 (es) Preparacion de derivados de ciclohexeno carboxilato.
ATE335748T1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
AU2003228770A8 (en) Substituted pyrazolopyrimidines
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
MXPA03010158A (es) Sulfonamidas.
SE9901077D0 (sv) Novel use
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AUPR118000A0 (en) Therapeutic molecules and methods
DE60221537D1 (de) Pteridinon-derivate als modulatoren der chemokinrezeptor-aktivität
PA8577701A1 (es) Polipeptido t20 pegilado
SE9801494D0 (sv) Novel use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties